![Joshua V. Funder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joshua V. Funder
Directeur/Bestuurslid bij Nuon Therapeutics, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Robert More | M | 56 |
Nuon Therapeutics, Inc.
![]() Nuon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nuon Therapeutics Inc. develops therapies to treat inflammation and neurological diseases. The company focuses on the development and commercialization of new therapies for autoimmune disease and inflammation includes rheumatoid arthritis and multiple sclerosis. Nuon Therapeutics was founded by Kim Puloma Kamdar, Marc Feldmann, Lawrence J. Steinman and Michael Selley in 2006 and is headquartered in San Mateo, CA. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Michael C. Venuti | M | 70 | 17 jaar | |
Vito Palombella | M | 61 | 12 jaar | |
Herm Rosenman | M | 76 | 4 jaar | |
John A. Barrett | M | 69 | 2 jaar | |
Paul Cossum | M | 71 |
Proacta, Inc.
![]() Proacta, Inc. BiotechnologyHealth Technology Proacta, Inc. develops drugs to treat cancer. It is developing a new generation of hypoxia-activated prodrug compounds to treat cancer. The firm’s lead product PR610, is a proprietary, hypoxia-activated prodrug with potential antineoplastic activity. The company was founded in 2001 by William A. Denny, Amato J. Giaccia, William Robert Wilson and Martin J. Brown and is headquartered in La Jolla, CA. | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 6 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Joshua V. Funder
- Persoonlijk netwerk